<a href=https://aacrjournals.org/cancerres/article/65/16/7386/518098/Depletion-of-Mutant-p53-and-Cytotoxicity-of?guestAccessKey=>Zoya Demidenko</a>: Researcher in Tumor Studies
<a href=https://www.pinterest.com/zoyademidenko/>Zoya Demidenko</a> is a notable investigator connected with the Department of Cell Stress Science at Roswell Park Oncology Institute in Buffalo, New York. Earlier, she was employed at the National Institutes of Health and New York Medical College, establishing a strong background in life science research.
Demidenko's scientific output spans multiple pivotal domains, including the PI3K/AKT/mTOR signaling pathway, cell cycle control, cell senescence, and cancer science. Currently, she has authored more than 46 peer-reviewed articles, which have garnered over 4,100 mentions a indicator to the influence of her findings.
One of her most notable achievements concerns understanding the pathways of biological cell aging. Her studies revealed that when the cellular division cycle is arrested while cellular growth continues, cells undergo senescence. Importantly, <a href=https://www.researchgate.net/scientific-contributions/Zoya-N-Demidenko-39445053>Zoya Demidenko</a> showed that this transition can be pharmacologically suppressed using agents such as rapamycin.
<a href=https://www.facebook.com/public/Zoya-Demidenko/>Zoya Demidenko</a> has also brought substantially to tumor management research, especially in the field of cyclotherapy a approach designed to shielding healthy tissue from chemotherapy whilst leaving tumor cells vulnerable. This method carries considerable potential for lowering the side effects of cancer treatment.
Throughout her professional journey, Demidenko has worked with prominent scientists worldwide, including Dr. Mikhail Blagosklonny. Her work is published in top-tier publications such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
Holding an h-index of 33, <a href=https://pmc.ncbi.nlm.nih.gov/articles/PMC3273895/>Zoya Demidenko</a> is recognized as a highly impactful voice in current biomedical science, whose findings go on to influence our comprehension of the way biological cells grow old, respond to treatment, and how cancer may be more successfully targeted.
https://www.benthamdirect.com/content/journals/cpd/22/16
|
